Audioptics Medical Inc.

Audioptics Medical Inc. is a Canadian company focused on innovative optical technologies that enhance diagnostic and treatment capabilities in the medical field, particularly in ophthalmology. Founded in 2016 in Halifax, Canada, Audioptics Medical Inc. specializes in providing advanced imaging systems utilizing proprietary optical coherence tomography (OCT) technology.

The company has successfully completed three deals, with its most recent funding round being Venture Debt of CAD 0. 49 million led by the Atlantic Canada Opportunities Agency on May 11, 2021. To date, Audioptics Medical Inc. has raised a total of CAD 1.

90 million. Dan MacDougall serves as the CEO. Audioptics Medical specializes in innovative optical technologies designed to enhance diagnostic and treatment capabilities in the medical field, particularly focusing on ophthalmology. The company's core product offerings include advanced imaging systems that utilize proprietary optical coherence tomography (OCT) technology, enabling healthcare professionals to visualize and analyze anatomical structures within the eye with unprecedented clarity.

These products address critical challenges faced by eye care specialists, such as the early detection of retinal diseases and monitoring of progressive conditions. Audioptics Medical serves a diverse client base that includes hospitals, specialized clinics, and diagnostic laboratories across North America and Europe, ensuring improved patient outcomes and enhanced diagnostic precision. Audioptics Medical generates revenue through a combination of direct sales and partnerships with healthcare providers, facilitating a streamlined transaction process. The company's flagship products are typically sold through a B2B model, where hospitals and clinics purchase the imaging systems directly, often accompanied by maintenance and support agreements.

Revenue is further supported by subscription-based services for software updates and data management, ensuring continuous access to the latest technology and features. Pricing plans are structured around the complexity and features of the imaging systems, reflecting the specialized nature of the products. In May 2021, Audioptics Medical Inc. secured CAD 0.

49 million in Venture Debt financing, which will be utilized to cover the regulatory approval process, develop five prototypes of the Audioptics system, and fund six new hires. The company is also planning to expand its market presence in North America and Europe. The upcoming product launches and enhancements are aimed at improving their existing offerings and reaching new clients.